Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 5337-5339, December 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allikmets, R.
Right arrow Articles by Dean, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allikmets, R.
Right arrow Articles by Dean, M.

A Human Placenta-specific ATP-Binding Cassette Gene (ABCP) on Chromosome 4q22 That Is Involved in Multidrug Resistance1

Rando Allikmets, Lynn M. Schriml, Amy Hutchinson, Vincenzo Romano-Spica and Michael Dean2

Intramural Research Support Program, Science Applications International Corporation-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 [R. A., A. H.]; National Cancer Institute, Laboratory of Genomic Diversity, Frederick, Maryland 21702-1201 [L. M. S., M. D.]; and Institute of Hygiene and Public Health, Faculty of Medicine of the Catholic University, 00168 Rome, Italy [V. R-S.]

We characterized a new human ATP-binding cassette (ABC) transporter gene that is highly expressed in the placenta. The gene, ABCP, produces two transcripts that differ at the 5' end and encode the same 655-amino acid protein. The predicted protein is closely related to the Drosophila white and yeast ADP1 genes and is a member of a subfamily that includes several multidrug resistance transporters. ABCP, white, and ADP1 all have a single ATP-binding domain at the NH2 terminus and a single COOH-terminal set of transmembrane segments. ABCP maps to human chromosome 4q22, between the markers D4S2462 and D4S1557, and the murine gene (Abcp) is located on chromosome 6 28–29 cM from the centromere. ABCP defines a new syntenic segment between human chromosome 4 and mouse chromosome 6. The abundant expression of this gene in the placenta suggests that the protein product has an important role in transport of specific molecule(s) into or out of this tissue.

1 This project was funded in part with Federal funds from the National Cancer Institute, NIH, under Contract No. NO1-CO-56000.

2 To whom requests for reprints should be addressed. Phone: (301) 846-5931; Fax: (301) 846-1909; E-mail: dean@mail.ncifcrf.gov.

Received 10/ 2/98. Accepted 10/19/98.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
K. K. W. To, Z. Zhan, T. Litman, and S. E. Bates
Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line
Mol. Cell. Biol., September 1, 2008; 28(17): 5147 - 5161.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. de Wolf, R. Jansen, H. Yamaguchi, M. de Haas, K. van de Wetering, J. Wijnholds, J. Beijnen, and P. Borst
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Mol. Cancer Ther., September 1, 2008; 7(9): 3092 - 3102.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Wang, E.-W. Lee, L. Zhou, P. C. K. Leung, D. D. Ross, J. D. Unadkat, and Q. Mao
Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells
Mol. Pharmacol., March 1, 2008; 73(3): 845 - 854.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Zhou, S. B. Naraharisetti, H. Wang, J. D. Unadkat, M. F. Hebert, and Q. Mao
The Breast Cancer Resistance Protein (Bcrp1/Abcg2) Limits Fetal Distribution of Glyburide in the Pregnant Mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study
Mol. Pharmacol., March 1, 2008; 73(3): 949 - 959.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Vore and M. Leggas
Progesterone Acts via Progesterone Receptors A and B to Regulate Breast Cancer Resistance Protein Expression
Mol. Pharmacol., March 1, 2008; 73(3): 613 - 615.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. K.W. To, O. Polgar, L. M. Huff, K. Morisaki, and S. E. Bates
Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells
Mol. Cancer Res., January 1, 2008; 6(1): 151 - 164.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Shukla, C.-P. Wu, K. Nandigama, and S. V. Ambudkar
The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2
Mol. Cancer Ther., December 1, 2007; 6(12): 3279 - 3286.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. A. Evseenko, P. Murthi, J. W. Paxton, G. Reid, B. S. Emerald, K. M. Mohankumar, P. E. Lobie, S. P. Brennecke, B. Kalionis, and J. A. Keelan
The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction
FASEB J, November 1, 2007; 21(13): 3592 - 3605.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. H. Storch, R. Ehehalt, W. E. Haefeli, and J. Weiss
Localization of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) in Lipid Rafts/Caveolae and Modulation of Its Activity by Cholesterol in Vitro
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 257 - 264.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
J. Lubelski, W. N. Konings, and A. J. M. Driessen
Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria
Microbiol. Mol. Biol. Rev., September 1, 2007; 71(3): 463 - 476.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L.-L. Hu, X.-X. Wang, X. Chen, J. Chang, C. Li, Y. Zhang, J. Yang, W. Jiang, and S.-M. Zhuang
BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma
Carcinogenesis, August 1, 2007; 28(8): 1740 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Xu, H. Peng, Q. Chen, Y. Liu, Z. Dong, and J.-T. Zhang
Oligomerization Domain of the Multidrug Resistance-Associated Transporter ABCG2 and Its Dominant Inhibitory Activity
Cancer Res., May 1, 2007; 67(9): 4373 - 4381.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. S. Lee, H.-E. Jeong, J.-M. Yi, H.-J. Jung, J.-E. Jang, E.-Y. Kim, S.-J. Lee, and J.-G. Shin
Identification and Functional Assessment of BCRP Polymorphisms in a Korean Population
Drug Metab. Dispos., April 1, 2007; 35(4): 623 - 632.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. K. W. To, Z. Zhan, and S. E. Bates
Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma
Mol. Cell. Biol., November 15, 2006; 26(22): 8572 - 8585.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev, October 1, 2006; 86(4): 1179 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. A. Seamon, C. A. Rugg, S. Emanuel, A. M. Calcagno, S. V. Ambudkar, S. A. Middleton, J. Butler, V. Borowski, and L. M. Greenberger
Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor.
Mol. Cancer Ther., October 1, 2006; 5(10): 2459 - 2467.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Tamura, M. Watanabe, H. Saito, H. Nakagawa, T. Kamachi, I. Okura, and T. Ishikawa
Functional Validation of the Genetic Polymorphisms of Human ATP-Binding Cassette (ABC) Transporter ABCG2: Identification of Alleles That Are Defective in Porphyrin Transport
Mol. Pharmacol., July 1, 2006; 70(1): 287 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Saito, H. Hirano, H. Nakagawa, T. Fukami, K. Oosumi, K. Murakami, H. Kimura, T. Kouchi, M. Konomi, E. Tao, et al.
A New Strategy of High-Speed Screening and Quantitative Structure-Activity Relationship Analysis to Evaluate Human ATP-Binding Cassette Transporter ABCG2-Drug Interactions
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1114 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Wang, L. Zhou, A. Gupta, R. R. Vethanayagam, Y. Zhang, J. D. Unadkat, and Q. Mao
Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E798 - E807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Henriksen, J. U. Fog, T. Litman, and U. Gether
Identification of Intra- and Intermolecular Disulfide Bridges in the Multidrug Resistance Transporter ABCG2
J. Biol. Chem., November 4, 2005; 280(44): 36926 - 36934.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Benderra, A. M. Faussat, L. Sayada, J.-Y. Perrot, R. Tang, D. Chaoui, H. Morjani, C. Marzac, J.-P. Marie, and O. Legrand
MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia
Clin. Cancer Res., November 1, 2005; 11(21): 7764 - 7772.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. A. Mathias, J. Hitti, and J. D. Unadkat
P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R963 - R969.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Shafran, I. Ifergan, E. Bram, G. Jansen, I. Kathmann, G. J. Peters, R. W. Robey, S. E. Bates, and Y. G. Assaraf
ABCG2 Harboring the Gly482 Mutation Confers High-Level Resistance to Various Hydrophilic Antifolates
Cancer Res., September 15, 2005; 65(18): 8414 - 8422.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Hirano, K. Maeda, S. Matsushima, Y. Nozaki, H. Kusuhara, and Y. Sugiyama
Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin
Mol. Pharmacol., September 1, 2005; 68(3): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Takada, H. Suzuki, Y. Gotoh, and Y. Sugiyama
REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
Drug Metab. Dispos., July 1, 2005; 33(7): 905 - 909.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. R. Vethanayagam, H. Wang, A. Gupta, Y. Zhang, F. Lewis, J. D. Unadkat, and Q. Mao
FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
Drug Metab. Dispos., June 1, 2005; 33(6): 697 - 705.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ahmed-Belkacem, A. Pozza, F. Munoz-Martinez, S. E. Bates, S. Castanys, F. Gamarro, A. Di Pietro, and J. M. Perez-Victoria
Flavonoid Structure-Activity Studies Identify 6-Prenylchrysin and Tectochrysin as Potent and Specific Inhibitors of Breast Cancer Resistance Protein ABCG2
Cancer Res., June 1, 2005; 65(11): 4852 - 4860.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Y. Frank, A. Margaryan, Y. Huang, T. Schatton, A. M. Waaga-Gasser, M. Gasser, M. H. Sayegh, W. Sadee, and M. H. Frank
ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma
Cancer Res., May 15, 2005; 65(10): 4320 - 4333.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Kolwankar, D. D. Glover, J. A. Ware, and T. S. Tracy
EXPRESSION AND FUNCTION OF ABCB1 AND ABCG2 IN HUMAN PLACENTAL TISSUE
Drug Metab. Dispos., April 1, 2005; 33(4): 524 - 529.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
U. Henriksen, U. Gether, and T. Litman
Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2
J. Cell Sci., April 1, 2005; 118(7): 1417 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. F. K. Ejendal and C. A. Hrycyna
Differential Sensitivities of the Human ATP-Binding Cassette Transporters ABCG2 and P-Glycoprotein to Cyclosporin A
Mol. Pharmacol., March 1, 2005; 67(3): 902 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ozvegy-Laczka, G. Varady, G. Koblos, O. Ujhelly, J. Cervenak, J. D. Schuetz, B. P. Sorrentino, G.-J. Koomen, A. Varadi, K. Nemet, et al.
Function-dependent Conformational Changes of the ABCG2 Multidrug Transporter Modify Its Interaction with a Monoclonal Antibody on the Cell Surface
J. Biol. Chem., February 11, 2005; 280(6): 4219 - 4227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Imai, E. Ishikawa, S. Asada, and Y. Sugimoto
Estrogen-Mediated Post transcriptional Down-regulation of Breast Cancer Resistance Protein/ABCG2
Cancer Res., January 15, 2005; 65(2): 596 - 604.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Kobayashi, I. Ieiri, T. Hirota, H. Takane, S. Maegawa, J. Kigawa, H. Suzuki, E. Nanba, M. Oshimura, N. Terakawa, et al.
FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA
Drug Metab. Dispos., January 1, 2005; 33(1): 94 - 101.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-P. Gillet, T. Efferth, D. Steinbach, J. Hamels, F. de Longueville, V. Bertholet, and J. Remacle
Microarray-based Detection of Multidrug Resistance in Human Tumor Cells by Expression Profiling of ATP-binding Cassette Transporter Genes
Cancer Res., December 15, 2004; 64(24): 8987 - 8993.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P.L. R. Ee, X. He, D. D. Ross, and W. T. Beck
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference
Mol. Cancer Ther., December 1, 2004; 3(12): 1577 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Benderra, A.-M. Faussat, L. Sayada, J.-Y. Perrot, D. Chaoui, J.-P. Marie, and O. Legrand
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Clin. Cancer Res., December 1, 2004; 10(23): 7896 - 7902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Zhao and X.-b. Chang
Mutation of the Aromatic Amino Acid Interacting with Adenine Moiety of ATP to a Polar Residue Alters the Properties of Multidrug Resistance Protein 1
J. Biol. Chem., November 19, 2004; 279(47): 48505 - 48512.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. F. Stewart, M. Leggas, J. D. Schuetz, J. C. Panetta, P. J. Cheshire, J. Peterson, N. Daw, J. J. Jenkins III, R. Gilbertson, G. S. Germain, et al.
Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice
Cancer Res., October 15, 2004; 64(20): 7491 - 7499.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Hirschmann-Jax, A. E. Foster, G. G. Wulf, J. G. Nuchtern, T. W. Jax, U. Gobel, M. A. Goodell, and M. K. Brenner
A distinct "side population" of cells with high drug efflux capacity in human tumor cells
PNAS, September 28, 2004; 101(39): 14228 - 14233.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Yanase, S. Tsukahara, S. Asada, E. Ishikawa, Y. Imai, and Y. Sugimoto
Gefitinib reverses breast cancer resistance protein-mediated drug resistance
Mol. Cancer Ther., September 1, 2004; 3(9): 1119 - 1125.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. A. de Jong, S. Marsh, R. H. J. Mathijssen, C. King, J. Verweij, A. Sparreboom, and H. L. McLeod
ABCG2 Pharmacogenetics: Ethnic Differences in Allele Frequency and Assessment of Influence on Irinotecan Disposition
Clin. Cancer Res., September 1, 2004; 10(17): 5889 - 5894.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Breedveld, N. Zelcer, D. Pluim, O. Sonmezer, M. M. Tibben, J. H. Beijnen, A. H. Schinkel, O. van Tellingen, P. Borst, and J. H. M. Schellens
Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles: Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions
Cancer Res., August 15, 2004; 64(16): 5804 - 5811.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. E. Bates, W. Y. Medina-Perez, G. Kohlhagen, S. Antony, T. Nadjem, R. W. Robey, and Y. Pommier
ABCG2 Mediates Differential Resistance to SN-38 (7-Ethyl-10-hydroxycamptothecin) and Homocamptothecins
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 836 - 842.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
C. T. Otsu, I. daSilva, J. B. de Molfetta, L. R. da Silva, J. de Almeida-Engler, G. Engler, P. C. Torraca, G. H. Goldman, and M. H. S. Goldman
NtWBC1, an ABC transporter gene specifically expressed in tobacco reproductive organs
J. Exp. Bot., August 1, 2004; 55(403): 1643 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Gupta, Y. Zhang, J. D. Unadkat, and Q. Mao
HIV Protease Inhibitors Are Inhibitors but Not Substrates of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 334 - 341.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Imai, S. Tsukahara, S. Asada, and Y. Sugimoto
Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance
Cancer Res., June 15, 2004; 64(12): 4346 - 4352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xu, Y. Liu, Y. Yang, S. Bates, and J.-T. Zhang
Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2
J. Biol. Chem., May 7, 2004; 279(19): 19781 - 19789.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Zhang, X. Yang, and M. E. Morris
Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport
Mol. Pharmacol., May 1, 2004; 65(5): 1208 - 1216.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
P. J. Houghton, G. S. Germain, F. C. Harwood, J. D. Schuetz, C. F. Stewart, E. Buchdunger, and P. Traxler
Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro
Cancer Res., April 1, 2004; 64(7): 2333 - 2337.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Yoh, G. Ishii, T. Yokose, Y. Minegishi, K. Tsuta, K. Goto, Y. Nishiwaki, T. Kodama, M. Suga, and A. Ochiai
Breast Cancer Resistance Protein Impacts Clinical Outcome in Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
Clin. Cancer Res., March 1, 2004; 10(5): 1691 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. W. Robey, K. Steadman, O. Polgar, K. Morisaki, M. Blayney, P. Mistry, and S. E. Bates
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
Cancer Res., February 15, 2004; 64(4): 1242 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. L. R. Ee, S. Kamalakaran, D. Tonetti, X. He, D. D. Ross, and W. T. Beck
Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene
Cancer Res., February 15, 2004; 64(4): 1247 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Nakanishi, L. A. Doyle, B. Hassel, Y. Wei, K. S. Bauer, S. Wu, D. W. Pumplin, H.-B. Fang, and D. D. Ross
Functional Characterization of Human Breast Cancer Resistance Protein (BCRP, ABCG2) Expressed in the Oocytes of Xenopus laevis
Mol. Pharmacol., December 1, 2003; 64(6): 1452 - 1462.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Y. Frank, S. S. Pendse, P. H. Lapchak, A. Margaryan, D. Shlain, C. Doeing, M. H. Sayegh, and M. H. Frank
Regulation of Progenitor Cell Fusion by ABCB5 P-glycoprotein, a Novel Human ATP-binding Cassette Transporter
J. Biol. Chem., November 21, 2003; 278(47): 47156 - 47165.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. L. A. Plasschaert, D. M. van der Kolk, E. S. J. M. de Bont, W. A. Kamps, K. Morisaki, S. E. Bates, G. L. Scheffer, R. J. Scheper, E. Vellenga, and E. G. E. de Vries
The Role of Breast Cancer Resistance Protein in Acute Lymphoblastic Leukemia
Clin. Cancer Res., November 1, 2003; 9(14): 5171 - 5177.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. L. Volk and E. Schneider
Wild-Type Breast Cancer Resistance Protein (BCRP/ABCG2) is a Methotrexate Polyglutamate Transporter
Cancer Res., September 1, 2003; 63(17): 5538 - 5543.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Imai, S. Asada, S. Tsukahara, E. Ishikawa, T. Tsuruo, and Y. Sugimoto
Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens
Mol. Pharmacol., September 1, 2003; 64(3): 610 - 618.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Wierdl, A. Wall, C. L. Morton, J. Sampath, M. K. Danks, J. D. Schuetz, and P. M. Potter
Carboxylesterase-Mediated Sensitization of Human Tumor Cells to CPT-11 Cannot Override ABCG2-Mediated Drug Resistance
Mol. Pharmacol., August 1, 2003; 64(2): 279 - 288.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.